Claire Hulme
Claire Hulme
Professor of Health Economics, University of Exeter
Verified email at exeter.ac.uk - Homepage
Title
Cited by
Cited by
Year
Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR …
D Jayne, A Pigazzi, H Marshall, J Croft, N Corrigan, J Copeland, P Quirke, ...
Jama 318 (16), 1569-1580, 2017
3712017
PET-CT surveillance versus neck dissection in advanced head and neck cancer
H Mehanna, WL Wong, CC McConkey, JK Rahman, M Robinson, ...
New England Journal of Medicine 374 (15), 1444-1454, 2016
2952016
Who will care? Employment participation and willingness to supply informal care
F Carmichael, S Charles, C Hulme
Journal of health economics 29 (1), 182-190, 2010
1692010
Workplace physical activity interventions: a systematic review
L Dugdill, A Brettle, C Hulme, S McCluskey, AF Long
International Journal of Workplace Health Management, 2008
1592008
Non‐pharmacological approaches for dementia that informal carers might try or access: a systematic review
C Hulme, J Wright, T Crocker, Y Oluboyede, A House
International journal of geriatric psychiatry 25 (7), 756-763, 2010
1422010
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-á) inhibitors, adalimumab and infliximab, for Crohn's disease.
J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, ...
Health Technology Assessment (Winchester, England) 15 (6), 1, 2011
1292011
Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review
C Kelly, C Hulme, T Farragher, G Clarke
BMJ open 6 (11), 2016
1162016
The TICOPA protocol (TIght COntrol of Psoriatic Arthritis): a randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis
LC Coates, N Navarro-Coy, SR Brown, S Brown, L McParland, H Collier, ...
BMC musculoskeletal disorders 14 (1), 101, 2013
1022013
Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome
SJ Bowman, CC Everett, JL O'Dwyer, P Emery, C Pitzalis, WF Ng, ...
Arthritis & Rheumatology 69 (7), 1440-1450, 2017
962017
The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk
TA Fairbairn, DM Meads, C Hulme, AN Mather, S Plein, DJ Blackman, ...
Heart 99 (13), 914-920, 2013
952013
Giving older workers a voice: constraints on the employment of older people in the North West of England
L Porcellato, F Carmichael, C Hulme, B Ingham, A Prashar
Work, Employment and Society 24 (1), 85-103, 2010
902010
A systematic review of the effectiveness and cost-effectiveness of peer education and peer support in prisons
AM Bagnall, J South, C Hulme, J Woodall, K Vinall-Collier, G Raine, ...
BMC Public Health 15 (1), 290, 2015
872015
Work–life imbalance: Informal care and paid employment in the UK
F Carmichael, C Hulme, S Sheppard, G Connell
Feminist Economics 14 (2), 3-35, 2008
872008
PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): randomised phase 3 non-inferiority trial with …
HM Earl, L Hiller, AL Vallier, S Loi, D Howe, HB Higgins, K McAdam, ...
Journal of Clinical Oncology 36 (15_suppl), 506-506, 2018
682018
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
HM Earl, L Hiller, AL Vallier, S Loi, K McAdam, L Hughes-Davies, ...
The Lancet 393 (10191), 2599-2612, 2019
632019
What is the cost of a healthy diet? Using diet data from the UK Women's Cohort Study
MA Morris, C Hulme, GP Clarke, KL Edwards, JE Cade
J Epidemiol Community Health 68 (11), 1043-1049, 2014
602014
Updated cost-effectiveness analysis of trastuzumab for early breast cancer
PS Hall, C Hulme, C McCabe, Y Oluboyede, J Round, DA Cameron
Pharmacoeconomics 29 (5), 415-432, 2011
602011
Cost effectiveness modelling for health technology assessment: a practical course
R Edlin, C McCabe, C Hulme, P Hall, J Wright
Springer, 2015
512015
Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial
J Bartlett, P Canney, A Campbell, D Cameron, J Donovan, J Dunn, H Earl, ...
Clinical oncology 25 (2), 109-116, 2013
492013
Urinary tract infections in children and the risk of ESRF
J Round, AC Fitzgerald, C Hulme, M Lakhanpaul, K Tullus
Acta Paediatrica 101 (3), 278-282, 2012
452012
The system can't perform the operation now. Try again later.
Articles 1–20